Saha, Vaskar
New Agents for the Treatment of Acute Lymphoblastic Leukemia
1. The Need for New Agents
Tim Eden
2. Identifying Targets for New Therapies in Children with Acute Lymphoblastic Leukemia
Shekhar Krishnan, Ashish Masurekar, Vaskar Saha
3. Preclinical Evaluation
Barbara Szymanska, Hernan Carol, Richard B. Lock
4. Design of Early-Phase Trials
James A. Whitlock, Terzah M. Horton
5. Strategies for Trial Design and Analyses
Maria Grazia Valsecchi, Paola Lorenzo
6. An Overview on Animal Models of ALL
Michael A. Batey, Josef H. Vormoor
7. Targeting Bcl-2 Family Proteins in Childhood Leukemia
Guy Makin, Caroline Dive
8. Targeting Leukemia Stem Cells and Stem Cell Pathways in ALL
Clare Pridans, Brian J. P. Huntly
9. Nucleoside Analogues
Pamela Kearns, Vaskar Saha
10. FLT3 Inhibitors as Therapeutic Agents in
Ronald W. Stam, Rob Pieters
11. The Role of Tyrosine Kinase Inhibitors in the Treatment of ALL
S. Wilson
12. Monoclonal Antibodies in Paediatric Acute Lymphoblastic Leukemia
Arend Stackelberg
13. Therapeutic Utility of Proteasome Inhibitors for Acute Leukemia
Joya Chandra, Claudia P. Miller
14. Targeting Epigenetic Pathways in ALL
Pamela Kearns
15. Incorporating New Therapies into Frontline Protocols
Paul S. Gaynon, Theresa M. Harned
Keywords: Biomedicine, Cancer Research, Pharmacology/Toxicology
- Author(s)
- Saha, Vaskar
- Kearns, Pamela
- Publisher
- Springer
- Publication year
- 2011
- Language
- en
- Edition
- 1
- Page amount
- 18 pages
- Category
- Medicine, Health Care, Mode
- Format
- Ebook
- eISBN (PDF)
- 9781441984593